BeiGene, Ltd. CEO John Oyler's 2018 pay jumps 171% to $28M
BeiGene, Ltd. reports 2018 executive compensation
By ExecPay News
Published: April 28, 2020
BeiGene, Ltd. reported fiscal year 2018 executive compensation information on April 28, 2020.
In 2018, six executives at BeiGene, Ltd. received on average a compensation package of $11M, a 150% increase compared to previous year.
Average pay of disclosed executives at BeiGene, Ltd.
John V. Oyler, Chief Executive Officer, received $28M in total, which increased by 171% compared to 2017. 60% of Oyler's compensation, or $17M, was in option awards. Oyler also received $562K in non-equity incentive plan, $650K in salary, $9.8M in stock awards, as well as $69K in other compensation.
Xiaobin Wu, General Manager of China and President, received a compensation package of $22M. 70% of the compensation package, or $15M, was in stock awards.
Howard Liang, Chief Financial Officer, earned $3.9M in 2018, a 9% increase compared to previous year.
Jane Huang, Chief Medical Officer, received $3.5M in 2018, which increases by 14% compared to 2017.
Amy Peterson, Chief Medical Officer, earned $3.4M in 2018, a 9% increase compared to previous year.
Hematology Amy Peterson, Chief Medical Officer, received $3.4M in 2018, which increases by 9% compared to 2017.
Related executives
Amy Peterson
BeiGene, Ltd.
Chief Medical Officer
John Oyler
BeiGene, Ltd.
Chief Executive Officer
Xiaobin Wu
BeiGene, Ltd.
General Manager of China and President
Howard Liang
BeiGene, Ltd.
Chief Financial Officer
Jane Huang
BeiGene, Ltd.
Chief Medical Officer
Hematology Peterson
BeiGene, Ltd.
Chief Medical Officer
You may also like
Source: SEC filing on April 28, 2020.